Taubert Jennifer L

EVP, WWC. Innovative Medicine at JNJ

Sold, on record
$36.9M
Dollars the filings state
Form 4 sales
4
Latest Aug 17, 2026
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • JNJJOHNSON & JOHNSONEVP, WWC. Innovative Medicine

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale JNJUnusual
    Nov 22, 2022 2022

    Sold 76,923 shares at $176.78 ($13.6M)

    Taubert Jennifer L, EVP, WW Chair, Pharmaceuticals

    Sold 37.8% of holdings ($36M position)126,456 shares leftFirst sale on recordFiling

  2. 2 Form 144 notice JNJNotice
    Feb 9, 2024 +444 days

    Filed to sell 59,397 shares ($9.3M)

    Taubert Jennifer L, Officer

    No 10b5-1 planFiling

  3. 3 Form 4 sale JNJUnusual
    Feb 9, 2024 same day

    Sold 59,397 shares at $156.27 ($9.3M)

    Taubert Jennifer L, EVP, WW Chair, Pharmaceuticals

    No 10b5-1 planSold 29.6% of holdings ($31.4M position)141,416 shares leftFollows a Form 144Filing

  4. 4 Form 4 sale JNJNo plan
    Sep 4, 2025 +573 days

    Sold 56,471 shares at $177.81 ($10M)

    Taubert Jennifer L, EVP, WWC. Innovative Medicine

    No 10b5-1 planSold 24.1% of holdings ($41.7M position)178,013 shares leftFiling

  5. 5 Form 4 sale JNJNo plan
    Aug 17, 2026 +347 days

    Sold 15,000 shares at $263.36 ($4M)

    Taubert Jennifer L, EVP, WWC. Innovative Medicine

    No 10b5-1 planSold 7.2% of holdings ($55.2M position)194,451 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Taubert Jennifer L
Source
Aug 17, 2026Aug 18, 2026JNJEVP, WWC. Innovative MedicineForm 4 sale15,000$4M7.2%No planSEC
Sep 4, 2025Sep 5, 2025JNJEVP, WWC. Innovative MedicineForm 4 sale56,471$10M24.1%No planSEC
Feb 9, 2024Feb 12, 2024JNJEVP, WW Chair, PharmaceuticalsForm 4 sale59,397$9.3M29.6%UnusualSEC
Feb 9, 2024Feb 9, 2024JNJOfficerForm 144 notice59,397$9.3MNoticeSEC
Nov 22, 2022Nov 23, 2022JNJEVP, WW Chair, PharmaceuticalsForm 4 sale76,923$13.6M37.8%UnusualSEC